Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NRx Pharmaceuticals Inc (NRXP)

  • Business News
  • Dec. 01, 2025, 13:03 UTC
  • 13
  • 1 comments

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

Market reaction Comment Full text

Tyra Biosciences Inc. (TYRA)

  • Business News
  • Dec. 01, 2025, 13:02 UTC
  • 14
  • 1 comments

Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer

Market reaction Comment Full text

TruBridge Inc. (TBRG)

  • Business News
  • Dec. 01, 2025, 13:01 UTC
  • 14
  • 1 comments

TruBridge, Inc.: TruBridge Announces the Refinancing of Credit Facilities

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 15
  • 1 comments

Agilent Technologies, Inc. - Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Market reaction Comment Full text

Sutro Biopharma Inc (STRO)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 14
  • 1 comments

Sutro Biopharma Announces 1-for-10 Reverse Stock Split

Market reaction Comment Full text

Cocrystal Pharma Inc. (COCP)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 21
  • 1 comments

Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference

Market reaction Comment Full text

INmune Bio Inc. (INMB)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 18
  • 1 comments

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimers Patients

Market reaction Comment Full text

ProQR Therapeutics (PRQR)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 10
  • 1 comments

ProQR to Participate in 8th Annual Evercore Healthcare Conference

Market reaction Comment Full text

Eli Lilly and Company (LLY)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 14
  • 1 comments

Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials

Market reaction Comment Full text

Solid Biosciences Inc (SLDB)

  • Business News
  • Dec. 01, 2025, 13:00 UTC
  • 18
  • 1 comments

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

Market reaction Comment Full text
  • Previous
  • 483
  • 484
  • 485
  • 486
  • 487
  • Next

Search

News categories

  • Technical Exchange News(10936)
  • Event(2373)
  • SEC News(191553)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125218)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin